Global Neuropathic Ocular Pain Market- Driver
Rise in awareness of the importance of eye health
An increase in awareness campaigns regarding the importance of eye health is expected to drive the market growth over the forecast period. For instance, in June 2021, the National Alliance for Eye and Vision Research (NAEVR), in collaboration with Tear Film & Ocular Surface Society Boston, a U.S.-based organization involved in educating people relating to eye health, announced that they hosted a dry eye awareness campaign in the U.S. to educate people regarding the importance of eye health.
An increase in collaboration and partnership by key market players
Key market players are adopting growth strategies such as partnerships and collaborations to launch new products. This is expected to drive the market growth over the forecast period. For instance, in October 2020, Ocular Therapeutix, Inc., a biopharmaceutical company, announced that it had collaborated with AffaMed Therapeutics, a clinical-stage biopharmaceutical company, to launch DEXTENZA, a U.S. FDA-approved product for the management of ocular pain, in Greater China, South Korea, and the ASEAN markets.
Figure 2. Global Neuropathic Ocular Pain Market Share (%), by Region, 2023
Neuropathic Ocular Pain Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients